Chinese Journal of Pharmaceuticals
|
2026, 57(2): 230-235
• Quality Management in Cell Therapy Product Manufacturing •
Key Points for Quality Management in the Production of Mesenchymal Stem Cell Drugs
Full
Fang DONG, Yansong MA, Ying KANG, Yimeng ZHOU*
Affiliations
- Center for Food and Drug Control, National Medical Products Administration, Beijing 100076
Published: 2026-02-10
doi: 10.16522/j.cnki.cjph.2026.02.014
Outline
董方, 马岩松, 康鹰, 周一萌.
间充质干细胞药品生产质量管理关注要点.
中国医药工业杂志,
2026
, 57
(2)
: 230
-235
.
DOI: 10.16522/j.cnki.cjph.2026.02.014
Fang DONG, Yansong MA, Ying KANG, Yimeng ZHOU.
Key Points for Quality Management in the Production of Mesenchymal Stem Cell Drugs[J].
Chinese Journal of Pharmaceuticals,
2026
, 57
(2)
: 230
-235
.
DOI: 10.16522/j.cnki.cjph.2026.02.014
Year 2026 volume 57 Issue 2
100
28
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2026.02.014
- Receive Date:2025-10-28
- Online Date:2026-11-05
- Published:2026-02-10